PlainRecalls
FDA Drug Moderate Class II Terminated

Buprenorphine and Naloxone Sublingual Film 2mg/0.5mg, 30 pouches each containing 1 sublingual film, Distributed by: Alvogen, Inc. Pine Brook, NJ 07058 USA, NDC 47781-355-03

Reported: July 14, 2021 Initiated: February 26, 2021 #D-0649-2021

Product Description

Buprenorphine and Naloxone Sublingual Film 2mg/0.5mg, 30 pouches each containing 1 sublingual film, Distributed by: Alvogen, Inc. Pine Brook, NJ 07058 USA, NDC 47781-355-03

Reason for Recall

Subpotent drug: Out of specification for assay of naloxone and buprenorphine (low)

Details

Recalling Firm
Alvogen, Inc
Units Affected
9,696 cartons
Distribution
USA nationwide.
Location
Morristown, NJ

Frequently Asked Questions

What product was recalled?
Buprenorphine and Naloxone Sublingual Film 2mg/0.5mg, 30 pouches each containing 1 sublingual film, Distributed by: Alvogen, Inc. Pine Brook, NJ 07058 USA, NDC 47781-355-03. Recalled by Alvogen, Inc. Units affected: 9,696 cartons.
Why was this product recalled?
Subpotent drug: Out of specification for assay of naloxone and buprenorphine (low)
Which agency issued this recall?
This recall was issued by the FDA Drug on July 14, 2021. Severity: Moderate. Recall number: D-0649-2021.